Skip to main content
. 2022 Jan 24;13(4):1282–1288. doi: 10.7150/jca.67523

Table 6.

Adverse events after TACE treatment

Adverse events DEB-TACE (N = 40) c-TACE (N = 49) P value
Vomiting/Nause 28 (70.0) 35 (71.4) 0.883
Abdominal pain 25 (62.5) 42 (85.7) 0.012
fever 16 (40.0) 26 (53.1) 0.220
Inguinal hematoma, No. (%) 2 (5.0) 2 (4.1) 0.836
Hepatic arterial dissection, No. (%) 2 (5.0) 1 (2.0) 0.441
Hepatorenal syndrome, No. (%) 1 (2.5) 0 (0.0) 0.204
Pulmonary oil embolization, No. (%) 0 (0.0) 0 (0.0) -

TACE,transarterial chemoembolization; DEB-TACE, drug-eluting beads transarterial chemoembolization; cTACE, conventional transarterial chemoembolization.